Version 5.4
Bos taurus Gene: APLN
Summary
InnateDB Gene IDBG-630479.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol APLN
Gene Name Apelin Apelin-36 Apelin-31 Apelin-28 Apelin-13
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000019993
Encoded Proteins
IDBP-681938
ApelinApelin-36Apelin-31Apelin-28Apelin-13
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary Currently no Entrez Summary Available. You might want to check the Summary Sections of the Orthologs.
Gene Information
Type Protein coding
Genomic Location Chromosome X:13559123-13564931
Strand Reverse strand
Band
Transcripts
ENSBTAT00000026630 ENSBTAP00000026630
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0005179 hormone activity
GO:0031704 apelin receptor binding
Biological Process
GO:0007165 signal transduction
Cellular Component
GO:0005576 extracellular region
Orthologs
No orthologs found for this gene
Pathways
NETPATH
REACTOME
REACT_219025
Peptide ligand-binding receptors pathway
REACT_205369
Signaling by GPCR pathway
REACT_210568
G alpha (i) signalling events pathway
REACT_214353
Signal Transduction pathway
REACT_214436
GPCR downstream signaling pathway
REACT_220217
GPCR ligand binding pathway
REACT_208412
Class A/1 (Rhodopsin-like receptors) pathway
KEGG
INOH
PID NCI
Cross-References
SwissProt Q9TUI9
TrEMBL
UniProt Splice Variant
Entrez Gene 282143
UniGene Bt.495
RefSeq NM_174503 XM_005227485
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AB023492
GenPept BAA84974
RNA Seq Atlas 282143

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca